MZE001 – Patient Worthy

Source: https://unsplash.com/photos/ZHys6xN7sUE

Phase 1 Trial Begins to Evaluate MZE001 for Pompe Disease

Post author:Jessica Lynn
Post published:February 18, 2022
Post category:Pompe Disease

According to a relatively recent news release from biopharmaceutical company Maze Therapeutics, the company has begun dosing healthy volunteers in a Phase 1 clinical trial. During the trial, researchers are…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More